Depression Research Today is a free monthly online journal that collates and summarizes the latest research about Depression, including details on clinical depression, medication, symptoms, treatment, counselling, therapy.

Volume 2 (2005), Issue 2 (February)

1. The relationship of fatigue to mental and physical health in a community sample.
   Soc Psychiatry Psychiatr Epidemiol, 40(2): 126-32. [Abstract] [Full-text]
2. St John's wort for depression: meta-analysis of randomised controlled trials.
   Br J Psychiatry, 186: 99-107. [Abstract] [Full-text]
3. Brief report: delinquent behaviour and depression in middle adolescence: a Finnish community sample.
   J Adolesc, 28(1): 155-9. [Abstract] [Full-text]
4. Hostility, depressive symptoms, and smoking in early adolescence.
   J Adolesc, 28(1): 49-62. [Abstract] [Full-text]
5. Low plasma vitamin E levels in major depression: diet or disease?
   Eur J Clin Nutr, 59(2): 304-6. [Abstract] [Full-text]
6. Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study.
   Int J Neuropsychopharmacol, 7(4): 481-7. [Abstract] [Full-text]
7. Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response.
   Int J Neuropsychopharmacol, 7(4): 501-6. [Abstract] [Full-text]
8. A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants.
   Int J Neuropsychopharmacol, 7(4): 471-9. [Abstract] [Full-text]
9. Depression, antidepressants and suicidality: a critical appraisal.
   Nat Rev Drug Discov, 4(2): 165-71. [Abstract] [Full-text]
10. Maternal depressive symptoms and children's receipt of health care in the first 3 years of life.
    Pediatrics, 115(2): 306-14. [Abstract] [Full-text]
11. Social and psychological characteristics of Kuwaiti children and adolescents with type 1 diabetes.
    Soc Sci Med, 60(8): 1835-44. [Abstract] [Full-text]
12. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.
    Biol Psychiatry, 57(3): 252-60. [Abstract] [Full-text]
13. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder.
    Biol Psychiatry, 57(3): 247-51. [Abstract] [Full-text]
14. Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression.
    Biol Psychiatry, 57(3): 220-8. [Abstract] [Full-text]
15. A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder.
    Biol Psychiatry, 57(3): 201-9. [Abstract] [Full-text]
16. Utility of a depression score to predict candidacy for hepatitis C virus therapy in veterans: a prospective longitudinal study.
    Aliment Pharmacol Ther, 21(3): 235-42. [Abstract] [Full-text]
17. Explaining variation in antidepressant prescribing rates in east London: a cross sectional study.
    Fam Pract, 22(1): 37-42. [Abstract] [Full-text]
18. Poststroke fatigue: characteristics and related factors.
    Cerebrovasc Dis, 19(2): 84-90. [Abstract] [Full-text]
19. The onset of postpartum depression: Implications for clinical screening in obstetrical and primary care.
    Am J Obstet Gynecol, 192(2): 522-6. [Abstract] [Full-text]
20. Women's postpartum stress, social support, and health status.
    West J Nurs Res, 27(2): 148-59; discussion 160-5. [Abstract] [Full-text]
21. Depressive symptoms are independently predictive of carotid atherosclerosis.
    Am J Cardiol, 95(4): 547-50. [Abstract] [Full-text]
22. Hypoalbuminemia in drug-free patients with major depressive disorder compared with a dietary matched control group: a clinical meaning beyond malnutrition.
    Eur Neuropsychopharmacol, 15(2): 227-30. [Abstract] [Full-text]
23. Higher cerebrospinal fluid homovanillic acid levels in depressed patients with comorbid posttraumatic stress disorder.
    Eur Neuropsychopharmacol, 15(2): 203-9. [Abstract] [Full-text]
24. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease.
    Atherosclerosis, 178(2): 339-44. [Abstract] [Full-text]
25. Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(2): 351-3. [Abstract] [Full-text]
26. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(2): 261-5. [Abstract] [Full-text]
27. Cytokines and major depression.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(2): 201-17. [Abstract] [Full-text]
28. Psychiatric and psychosocial outcome of cardiac surgery with cardiopulmonary bypass: a prospective 12-month follow-up study.
    Gen Hosp Psychiatry, 27(1): 18-28. [Abstract] [Full-text]
29. Psychopathology and personality features in orthopedic patients with boxer's fractures.
    Gen Hosp Psychiatry, 27(1): 13-7. [Abstract] [Full-text]
30. Improving depression outcomes in older adults with comorbid medical illness.
    Gen Hosp Psychiatry, 27(1): 4-12. [Abstract] [Full-text]
31. Specificity of autobiographical memories and basal cortisol levels in patients with major depression.
    Psychoneuroendocrinology, 30(4): 403-11. [Abstract] [Full-text]
32. The combined T3/TRH test in depressed patients and healthy controls.
    Psychoneuroendocrinology, 30(4): 341-56. [Abstract] [Full-text]
33. Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study.
    Psychoneuroendocrinology, 30(4): 309-15. [Abstract] [Full-text]
34. Mild depression in young adults with cerebral infarction at long-term follow-up: a population-based study.
    Eur J Neurol, 12(3): 194-8. [Abstract] [Full-text]
35. Psychological distress among Bam earthquake survivors in Iran: a population-based study.
    BMC Public Health, 5(1): 4. [Abstract] [Full-text]
36. A prospective study of predictors of poststroke depression.
    Neurology, 64(3): 428-33. [Abstract] [Full-text]
37. Maternal depression and children's antisocial behavior: nature and nurture effects.
    Arch Gen Psychiatry, 62(2): 173-81. [Abstract] [Full-text]
38. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Arch Gen Psychiatry, 62(2): 154-62. [Abstract] [Full-text]
39. Explanatory style change in supportive-expressive dynamic therapy.
    J Clin Psychol, 61(3): 257-68. [Abstract] [Full-text]
40. Cortisol response to ovine corticotropin-releasing hormone in a model of pregnancy and parturition in euthymic women with and without a history of postpartum depression.
    J Clin Endocrinol Metab, 90(2): 695-9. [Abstract] [Full-text]
41. Validation of a behavioral health treatment outcome and assessment tool designed for naturalistic settings: The Treatment Outcome Package.
    J Clin Psychol, 61(3): 285-314. [Abstract] [Full-text]
42. Unprecedented improvements in short-term heart rate variability due to Thought Field Therapy: response to the Pignotti retraction.
    J Clin Psychol, 61(3): 367-72. [Abstract] [Full-text]
43. Plasma leptin in men and women with seasonal affective disorder and in healthy matched controls.
    Horm Metab Res, 37(1): 45-8. [Abstract] [Full-text]
44. Depression increasingly predicts mortality in the course of congestive heart failure.
    Eur J Heart Fail, 7(2): 261-7. [Abstract] [Full-text]
45. Receipt of negative feedback is related to increased negative feedback seeking among individuals with depressive symptoms.
    Behav Res Ther, 43(4): 485-504. [Abstract] [Full-text]
46. The effects of social anxiety and depression on the evaluation of facial crowds.
    Behav Res Ther, 43(4): 467-74. [Abstract] [Full-text]
47. The Reynolds Adolescent Depression Scale in New Zealand adolescents.
    Aust N Z J Psychiatry, 39(3): 136-40. [Abstract] [Full-text]
48. Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression.
    Psychopharmacology (Berl), 178(1): 58-66. [Abstract] [Full-text]
49. Pathological correlates of poststroke depression in elderly patients.
    Am J Geriatr Psychiatry, 13(2): 166-9. [Abstract] [Full-text]
50. Social support and locus of control as predictors of adherence to antidepressant medication in an elderly population.
    Am J Geriatr Psychiatry, 13(2): 157-65. [Abstract] [Full-text]
51. Symptom profile of DSM-IV major and minor depressive disorders in first-ever stroke patients.
    Am J Geriatr Psychiatry, 13(2): 108-15. [Abstract] [Full-text]
52. Depression-executive dysfunction syndrome in stroke patients.
    Am J Geriatr Psychiatry, 13(2): 99-107. [Abstract] [Full-text]
53. Cerebrovascular disease and late-life depression.
    Am J Geriatr Psychiatry, 13(2): 88-98. [Abstract] [Full-text]
54. Depressive realism and outcome density bias in contingency judgments: the effect of the context and intertrial interval.
    J Exp Psychol Gen, 134(1): 10-22. [Abstract] [Full-text]
55. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Pharmacopsychiatry, 38(1): 30-5. [Abstract] [Full-text]
56. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
    Pharmacopsychiatry, 38(1): 13-6. [Abstract] [Full-text]
57. Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression.
    Biol Psychiatry, 57(4): 412-21. [Abstract] [Full-text]
58. Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats.
    Biol Psychiatry, 57(4): 343-50. [Abstract] [Full-text]
59. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression.
    Biol Psychiatry, 57(4): 336-42. [Abstract] [Full-text]
60. Electroencephalographic measures of regional hemispheric activity in offspring at risk for depressive disorders.
    Biol Psychiatry, 57(4): 328-35. [Abstract] [Full-text]
61. Toward an objective characterization of an anhedonic phenotype: a signal-detection approach.
    Biol Psychiatry, 57(4): 319-27. [Abstract] [Full-text]
62. Psychiatric disorders and large interdialytic weight gain in patients on chronic haemodialysis.
    Nephrology (Carlton), 10(1): 15-20. [Abstract] [Full-text]
63. Detecting depression in Alzheimer's disease: evaluation of four different scales.
    Arch Clin Neuropsychol, 20(2): 271-6. [Abstract] [Full-text]
64. Searching for behavioral indicators of bipolar II in patients presenting with major depressive episodes: the "red sign," the "rule of three" and other biographic signs of temperamental extravagance, activation and hypomania.
    J Affect Disord, 84(2): 279-90. [Abstract] [Full-text]
65. Antidepressant-associated chronic irritable dysphoria (acid) in bipolar disorder: a case series.
    J Affect Disord, 84(2): 267-72. [Abstract] [Full-text]
66. Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament.
    J Affect Disord, 84(2): 259-66. [Abstract] [Full-text]
67. A closer look at treatment resistant depression: is it due to a bipolar diathesis?
    J Affect Disord, 84(2): 251-7. [Abstract] [Full-text]
68. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    J Affect Disord, 84(2): 243-9. [Abstract] [Full-text]
69. Is migraine in unipolar depressed patients a bipolar spectrum trait?
    J Affect Disord, 84(2): 233-42. [Abstract] [Full-text]
70. Temperament in the clinical differentiation of depressed bipolar and unipolar major depressive patients.
    J Affect Disord, 84(2): 219-23. [Abstract] [Full-text]
71. Atypical depression: a variant of bipolar II or a bridge between unipolar and bipolar II?
    J Affect Disord, 84(2): 209-17. [Abstract] [Full-text]
72. Irritable-hostile depression: further validation as a bipolar depressive mixed state.
    J Affect Disord, 84(2): 197-207. [Abstract] [Full-text]
73. Irritable psychomotor elation in depressed inpatients: a factor validation of mixed depression.
    J Affect Disord, 84(2): 187-96. [Abstract] [Full-text]
74. High rate of unrecognized bipolar mixed states among destitute Hispanic adolescents referred for "major depressive disorder".
    J Affect Disord, 84(2): 179-86. [Abstract] [Full-text]
75. The high prevalence of bipolar spectrum disorders in young adults with recurrent depression: toward an innovative diagnostic framework.
    J Affect Disord, 84(2): 167-78. [Abstract] [Full-text]
76. Profiles of "manic" symptoms in bipolar I, bipolar II and major depressive disorders.
    J Affect Disord, 84(2): 159-66. [Abstract] [Full-text]
77. Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions.
    J Affect Disord, 84(2): 149-57. [Abstract] [Full-text]
78. Bipolar mood disorders among Polish psychiatric outpatients treated for major depression.
    J Affect Disord, 84(2): 141-7. [Abstract] [Full-text]
79. Dimensional psychopathology of depression: detection of an 'activation' dimension in unipolar depressed outpatients.
    J Affect Disord, 84(2): 133-9. [Abstract] [Full-text]
80. Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures.
    J Affect Disord, 84(2): 127-32. [Abstract] [Full-text]
81. A different depression: clinical distinctions between bipolar and unipolar depression.
    J Affect Disord, 84(2): 117-25. [Abstract] [Full-text]
82. The dark side of bipolarity: detecting bipolar depression in its pleomorphic expressions.
    J Affect Disord, 84(2): 107-15. [Abstract] [Full-text]
83. Serotonergic modulation of mismatch negativity.
    Psychiatry Res, 138(1): 61-74. [Abstract] [Full-text]
84. Anger and depression in cocaine addiction: association with the orbitofrontal cortex.
    Psychiatry Res, 138(1): 13-22. [Abstract] [Full-text]
85. Boundary ambiguity, coping patterns and depression in mothers caring for children with epilepsy in Taiwan.
    Int J Nurs Stud, 42(3): 273-82. [Abstract] [Full-text]
86. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.
    J Ethnopharmacol, 97(2): 281-4. [Abstract] [Full-text]
87. Prevalence and correlates of depression as a secondary condition among adults with disabilities.
    Am J Orthopsychiatry, 75(1): 76-85. [Abstract] [Full-text]
88. Coparenting conflict, nonacceptance, and depression among divorced adults: results from a 12-year follow-up study of child custody mediation using multiple imputation.
    Am J Orthopsychiatry, 75(1): 63-75. [Abstract] [Full-text]
89. Validity of sudden gains in acute phase treatment of depression.
    J Consult Clin Psychol, 73(1): 173-82. [Abstract] [Full-text]
90. Cognitive changes, critical sessions, and sudden gains in cognitive-behavioral therapy for depression.
    J Consult Clin Psychol, 73(1): 168-72. [Abstract] [Full-text]
91. Long-term outcome of a school-based, universal approach to prevention of depression in adolescents.
    J Consult Clin Psychol, 73(1): 160-7. [Abstract] [Full-text]
92. Two-year prospective naturalistic study of remission from major depressive disorder as a function of personality disorder comorbidity.
    J Consult Clin Psychol, 73(1): 78-85. [Abstract] [Full-text]
93. Unlinking negative cognition and symptoms of depression: evidence of a specific treatment effect for cognitive therapy.
    J Consult Clin Psychol, 73(1): 68-77. [Abstract] [Full-text]
94. Sudden gains in cognitive therapy for depression: a replication and extension.
    J Consult Clin Psychol, 73(1): 59-67. [Abstract] [Full-text]
95. Measurement equivalence of the center for epidemiological studies depression scale for Latino and Anglo adolescents: a national study.
    J Consult Clin Psychol, 73(1): 47-58. [Abstract] [Full-text]
96. Potential mediators of cognitive-behavioral therapy for adolescents with comorbid major depression and conduct disorder.
    J Consult Clin Psychol, 73(1): 38-46. [Abstract] [Full-text]
97. Dietary restraint, body dissatisfaction, and psychological distress: a prospective analysis.
    J Abnorm Psychol, 114(1): 119-25. [Abstract] [Full-text]
98. Is depression best viewed as a continuum or discrete category? A taxometric analysis of childhood and adolescent depression in a population-based sample.
    J Abnorm Psychol, 114(1): 96-110. [Abstract] [Full-text]
99. A comparison of attentional biases and memory biases in women with social phobia and major depression.
    J Abnorm Psychol, 114(1): 62-74. [Abstract] [Full-text]
100. Cognitive processing of emotional information in depression, panic, and somatoform disorder.
     J Abnorm Psychol, 114(1): 50-61. [Abstract] [Full-text]
101. Neighborhood context, personality, and stressful life events as predictors of depression among African American women.
     J Abnorm Psychol, 114(1): 3-15. [Abstract] [Full-text]
102. Association analysis of apolipoprotein E genotype and risk of depressive symptoms in Alzheimer's disease.
     Dement Geriatr Cogn Disord, 19(2): 154-7. [Abstract] [Full-text]
103. Assessing dimensional and categorical aspects of depression: validation of the AMDP Depression Scale.
     Eur Arch Psychiatry Clin Neurosci, 255(1): 15-9. [Abstract] [Full-text]
104. Hypericum extract LI 160 and fluoxetine in mild to moderate depression: a randomized, placebo-controlled multi-center study in outpatients.
     Eur Arch Psychiatry Clin Neurosci, 255(1): 40-7. [Abstract] [Full-text]
105. Premenstrual dysphoric symptoms amongst Brazilian college students: factor structure and methodological appraisal.
     Eur Arch Psychiatry Clin Neurosci, 255(1): 51-6. [Abstract] [Full-text]
106. Signal transduction abnormalities in melancholic depression.
     Int J Neuropsychopharmacol, 8(1): 5-16. [Abstract] [Full-text]
107. The many faces of fatigue in major depressive disorder.
     Int J Neuropsychopharmacol, 8(1): 93-105. [Abstract] [Full-text]
108. Obesity among outpatients with major depressive disorder.
     Int J Neuropsychopharmacol, 8(1): 59-63. [Abstract] [Full-text]
109. Psychosocial aspects of lung cancer.
     Lung Cancer, 47(3): 293-300. [Abstract] [Full-text]
110. Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression.
     Endocrinology, 146(3): 1338-47. [Abstract] [Full-text]
111. Examining the construct of depression in obstructive sleep apnea syndrome.
     Sleep Med, 6(2): 115-21. [Abstract] [Full-text]
112. Exercise as a treatment for depression in elders.
     J Am Acad Nurse Pract, 17(2): 60-6. [Abstract] [Full-text]
113. Use of seclusion in a psychiatric acute inpatient unit.
     Australas Psychiatry, 12(4): 347-51. [Abstract] [Full-text]
114. Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'.
     Int J Geriatr Psychiatry, 20(2): 119-27. [Abstract] [Full-text]
115. Physical health, depression and cognitive function as correlates of disability in an older Korean population.
     Int J Geriatr Psychiatry, 20(2): 160-7. [Abstract] [Full-text]
116. Voluntary alcohol intake in two rat lines selectively bred for learned helpless and non-helpless behavior.
     Psychopharmacology (Berl), 178(2): 125-32. [Abstract] [Full-text]
117. Neuropeptide expression in rats exposed to chronic mild stresses.
     Psychopharmacology (Berl), 178(2): 115-24. [Abstract] [Full-text]
118. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials.
     BMJ, 330(7488): 396. [Abstract] [Full-text]
119. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.
     BMJ, 330(7488): 389. [Abstract] [Full-text]
120. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review.
     BMJ, 330(7488): 385. [Abstract] [Full-text]
121. Patients with heart failure in primary health care: effects of a nurse-led intervention on health-related quality of life and depression.
     Eur J Heart Fail, 7(3): 393-403. [Abstract] [Full-text]
122. Depression vulnerability, cigarette smoking, and the serotonin transporter gene.
     Addict Behav, 30(3): 557-66. [Abstract] [Full-text]
123. Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy.
     Neuropsychopharmacology, 30(3): 445-60. [Abstract] [Full-text]
124. Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behavior.
     Psychopharmacology (Berl), 178(2): 276-85. [Abstract] [Full-text]
125. Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.
     Psychopharmacology (Berl), 178(2): 303-8. [Abstract] [Full-text]
126. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment.
     Psychopharmacology (Berl), 178(2): 161-6. [Abstract] [Full-text]
127. A case of seasonal bipolar disorder exacerbated by Cushing's disease.
     Compr Psychiatry, 46(2): 155-8. [Abstract] [Full-text]
128. Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.
     Compr Psychiatry, 46(2): 81-9. [Abstract] [Full-text]
129. Investigation of transcription factor AP-2 beta genotype in women with premenstrual dysphoric disorder.
     Neurosci Lett, 377(1): 49-52. [Abstract] [Full-text]
130. A comparison between socially anxious and depressive symptomatology in youth: a focus on perceived family environment.
     J Anxiety Disord, 19(4): 423-42. [Abstract] [Full-text]
131. Caring for depressed patients in rural communities: general practitioners' attitudes, needs and relationships with mental health services.
     Aust J Rural Health, 13(1): 21-7. [Abstract] [Full-text]
132. Effects of emotional disclosure on psychological and physiological outcomes in patients with rheumatoid arthritis: an exploratory home-based study.
     J Health Psychol, 10(2): 277-85. [Abstract] [Full-text]
133. Effect of a brief cognitive training programme in patients with long-lasting back pain evaluated as unfit for surgery.
     J Health Psychol, 10(2): 233-43. [Abstract] [Full-text]
134. Decreased depression up to one year following CBSM+ intervention in depressed women with AIDS: the smart/EST women's project.
     J Health Psychol, 10(2): 223-31. [Abstract] [Full-text]
135. The effects of expressive writing on pain, depression and posttraumatic stress disorder symptoms in survivors of intimate partner violence.
     J Health Psychol, 10(2): 211-21. [Abstract] [Full-text]
136. White matter hyperintensities and chronicity of depression.
     J Psychiatr Res, 39(3): 285-93. [Abstract] [Full-text]
137. Prevalence and comorbidity of major depressive disorder in young black and white women.
     J Psychiatr Res, 39(3): 275-83. [Abstract] [Full-text]
138. Impact of postpartum depression on the mother-infant couple.
     Birth, 32(1): 39-44. [Abstract] [Full-text]
139. Effectiveness of a counseling intervention after a traumatic childbirth: a randomized controlled trial.
     Birth, 32(1): 11-9. [Abstract] [Full-text]
140. Stability of visual acuity measurement in depression.
     Am J Geriatr Psychiatry, 13(3): 255-8. [Abstract] [Full-text]
141. IADL functions, cognitive deficits, and severity of depression: a preliminary study.
     Am J Geriatr Psychiatry, 13(3): 244-9. [Abstract] [Full-text]
142. Duloxetine for the treatment of major depressive disorder in older patients.
     Am J Geriatr Psychiatry, 13(3): 227-35. [Abstract] [Full-text]
143. How does depression influence diabetes medication adherence in older patients?
     Am J Geriatr Psychiatry, 13(3): 202-10. [Abstract] [Full-text]
144. Body pain and treatment response in late-life depression.
     Am J Geriatr Psychiatry, 13(3): 188-94. [Abstract] [Full-text]
145. Major and subthreshold depression among older adults seeking vision rehabilitation services.
     Am J Geriatr Psychiatry, 13(3): 180-7. [Abstract] [Full-text]
146. Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram.
     J Psychopharmacol, 19(2): 166-72. [Abstract] [Full-text]
147. Moderate alcohol use and depression in young adults: findings from a national longitudinal study.
     Am J Public Health, 95(3): 453-7. [Abstract] [Full-text]
148. A confirmatory model for depression among Japanese American and part-Japanese American adolescents.
     Cultur Divers Ethnic Minor Psychol, 11(1): 41-56. [Abstract] [Full-text]
149. Age of first onset major depression in Chinese Americans.
     Cultur Divers Ethnic Minor Psychol, 11(1): 16-27. [Abstract] [Full-text]
150. Understanding academic attitudes and achievement in mexican-origin youths: ethnic identity, other-group orientation, and fatalism.
     Cultur Divers Ethnic Minor Psychol, 11(1): 3-15. [Abstract] [Full-text]
151. Improvement of dry mouth by replacing paroxetine with fluvoxamine.
     Ann Pharmacother, 39(3): 567-71. [Abstract] [Full-text]
152. Maternal negative affect and perceptions of "problem children" in the family.
     Child Psychiatry Hum Dev, 35(3): 203-25. [Abstract] [Full-text]
153. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
     Addiction, 100: 23-31. [Abstract] [Full-text]
154. New developments in antidepressant therapy.
     Nurs Clin North Am, 40(1): 95-105, vii. [Abstract] [Full-text]
155. Predictors and Correlates of Fatigue in HIV/AIDS.
     J Pain Symptom Manage, 29(2): 173-84. [Abstract] [Full-text]
156. The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation.
     J Pain Symptom Manage, 29(2): 130-55. [Abstract] [Full-text]
157. Interferon-induced depression: prevalence and management.
     Dig Liver Dis, 37(2): 102-7. [Abstract] [Full-text]
158. Interpersonal psychotherapy: an effective psychotherapeutic intervention for mental health nursing practice.
     Int J Ment Health Nurs, 14(1): 24-31. [Abstract] [Full-text]

© 2004-2008 Depression Research Today. All Rights Reserved.